313
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement

, , , , ORCID Icon, , , ORCID Icon, , , ORCID Icon, , & show all
Pages 2980-2984 | Received 17 Apr 2020, Accepted 27 Jun 2020, Published online: 10 Jul 2020
 

Acknowledgments

PS salary supported by the Lymphoma Research Foundation Career Development Award Grant.

Author contributions

FF collected clinical data and wrote the paper; LJN, FS, LEF, PAT, BD, CCP, SSN and RES provided clinical care to patients and coauthored the paper; GW and MWM collected clinical data and coauthored the paper; RKS reviewed pathological findings and coauthored the paper; LC reviewed neuro-radiological findings and coauthored the paper; PS designed the study, collected and analyzed the data, provided clinical care to patients, and wrote the paper.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The study was partially supported by MD Anderson Cancer Center Support grant CA016672.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.